Q4 · MEDICINE
Article
Author: Jeffrey, Phillip ; O'Hanlon, Peter J. ; Muir, Alison I. ; Stemp, Geoffrey ; Johnson, Christopher N. ; Winborn, Kim Y. ; Stevens, Alex J. ; Al-Barazanji, Kamal ; Witty, David R. ; Haynes, Andrea ; Thewlis, Kevin ; Hervieu, Guillaume J. ; Hamprecht, Dieter ; Bateson, John
A strategy of systematically targeting more rigid analogues of the known MCH R1 receptor antagonist, SB-568849, serendipitously uncovered a binding mode accessible to N-aryl-phthalimide ligands. Optimisation to improve the stability of this compound class led to the discovery of novel N-aryl-quinazolinones, benzotriazinones and thienopyrimidinones as selective ligands with good affinity for human melanin-concentrating hormone receptor 1.